01/20/2013 02:20 pm ET Updated Mar 22, 2013

Fiscal Footnote: Big Senate Gift to Drug Maker

WASHINGTON — Just two weeks after pleading guilty in a major federal fraud case, Amgen, the world’s largest biotechnology firm, scored a largely unnoticed coup on Capitol Hill: Lawmakers inserted a paragraph into the “fiscal cliff” bill that did not mention the company by name but strongly favored one of its drugs.

Read more on nytimes.com